Peptides have become one of the most exciting frontiers in modern health, wellness, and biotechnology research. Unlike proteins, which are typically composed of long chains of amino acids, peptides are shorter sequences that can wield significant influence on the body’s physiological and biochemical processes. While many individuals may have heard of peptides like collagen peptides for skin health or creatine peptides for muscle performance, a new wave of advanced and highly specialized peptides is quickly garnering attention among researchers. One promising candidate is SLU-PP-332.
SLU-PP-332 is touted by some researchers as a potentially versatile agent, with studies hinting at its efficacy in various areas—ranging from supporting skin integrity to possibly contributing to muscle repair and inflammatory response modulation. But what exactly is SLU-PP-332, and how does it work? Most importantly, why should the public care about it?
SLU-PP-332 is a synthetic small molecule recognized as a potent but non-selective agonist of the estrogen-related receptor (ERR), displaying its strongest activity at ERRα with an EC50 of 98 nM. It has attracted attention in biomedical research for potential applications in metabolic health and exercise mimetics. Synthesized in the early 2000s at Saint Louis University School of Medicine reflected by the “SLU” prefix this compound represents a novel category of ERR modulators engineered to selectively engage ERR pathways without exhibiting estrogenic effects.